BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
Cangene is defunct.

Fate: Acquired by Emergent Biosolutions, Dec 2013, $222M


------------------
If you believe any of this information is incorrect, please let us know.